Evidence-Based Interventions to Improve Sleep Health
Carolyn Toth, RN, MSN FNP-S & Annie Thomas PhD, RN
Loyola University of Chicago, Marcella Niehoff School of Nursing
Background & Significance
•
•
•

Insufficient sleep is associated with a multitude of
adverse health outcomes and many serious public
health implications.
Insomnia is the most common disorder that causes
insufficient sleep and is one of the top complaints
reported in primary care in the U.S (Taylor et al., 2017).
Despite its prevalence, insomnia continues to be under
diagnosed and treated ineffectively (Zhou et al., 2017).

Purpose
•
•

There are currently many underutilized, evidence-based
treatments available for insomnia and new, emerging
treatment options.
The purpose this review is to help close the gap between
current clinical guidelines and current clinical practice for
treating insomnia.

Synthesis of Evidence
• Clinicians need to modify their practice to close the gap
between current clinical guidelines for evaluating and
treating insomnia and current clinical practice.
• Providers can aid in reducing the ubiquity, economic
burden, and health disparities associated with insomnia.
• Evidence-based interventions with strong evidence across
multiple sleep outcomes include cognitive behavioral
therapy, digital cognitive behavioral therapy, and brief
behavioral intervention should be utilized as first line
treatment (Zhou et al, 2017.
• Pharmacological treatment should only be used short term
(<4 weeks) and in conjunction with non-pharmacological
treatment.

Clinical Algorithm for Treating Insomnia

Search Strategy
•
•

A literature search was conducted using the search
terms “insomnia” and “evidence-based interventions”
on the databases CINAHL, PubMed, and Scopus.
The search was restricted to 2015-2020, human subjects,
and English language.

•

•

40 articles were retrieved and reviewed and 29 yielded
results.
Insomnia has been traditionally treated with
pharmacological agents such as benzodiazepine
receptor agonists (BZRAs), but the evidence backing the
use of these drugs is minimal to moderate. The harms
associated are extensive (Lee et al., 2019).
Cognitive behavioral therapy for insomnia (CBT-I) has
undoubtedly the most evidence backing its use for the
treatment of insomnia and should always be used as the
first line treatment.	
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Guidelines for Deprescribing BZRAs

CBT-I Components

Note. Reprinted from Pierpaoli Parker, C. Cognitive Behavioral Therapy for Insomnia
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• Clinicians must discuss sleep with every patient at every
visit. Sleep quality assessments are an important early risk
indicator that can reduce the incidence of a wide spectrum
of morbidities.
• Clinicians can shift the paradigm surrounding medication
usage for insomnia by deprescribing BZRAs.
• If pharmacological treatment is indicated then a short
course of less than 2-4 weeks of low dose melatonin,
ramelteon, zolpidem, suvorexant, or doxepin are the most
safe and effective across multiple sleep outcomes (Rios et
al., 2019).
• Clinicians must utilize CBT-I and be aware of digital CBT-I
like Somryst which is the first FDA approved digital CBT-I
and is nearly as effective as in person CBT-I.
• Exercise and mindfulness-based treatment can be used as
complementary interventions to CBT-I/digital CBT-I.
depending on the patient’s interest. Those have moderate
evidence backing its efficacy.
Conclusion: Primary care health providers can help
decrease the public health issue of insomnia by basing
treatment plans on evidence-based guidelines and by not
initiating BZRA treatment especially in older adults.

Digital CBT-I

Results of Literature Search
•

Implications for Practice and Conclusion

Note. Reprinted from Lee, J. Y., Farrell, B., & Holbrook, A. M. (2019). Deprescribing
benzodiazepine receptor agonists taken for insomnia: a review and key messages from
practice guidelines. Polish archives of internal medicine, 129(1), 43–49.
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